The Clinical and Regulatory Affairs team at MeiraGTx plays a crucial role in overseeing the development and approval processes for novel gene therapies. This team ensures compliance with regulatory standards, manages clinical trials, monitors product safety, and facilitates communication with regulatory authorities to bring innovative treatments to market. Their expertise spans clinical research, regulatory strategy, pharmacovigilance, and quality assurance, all aimed at transforming patient lives through effective therapies.
Beatrice Ranahan
Quality Assurance Specialist
Elke Vansnick
Director Clinical Data Managem...
Kendra Sale
Contract Clinical Research Ass...
Maegan Little
Senior Manager, Regulatory Aff...
Nathalie Dubois
Head Of Pharmacovigilance
Robert K. Zeldin
Chief Medical Officer
Suhayl Bunally
QA Associate
Tassos Georgiadis
VP Preclinical Development
Toyin Adefila-Ideozu
Senior Histology Scientist
View all